Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.

Autor: Prelog M; Pediatric Rheumatology / Special Immunology, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany., Jeske SD; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany., Asam C; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany., Fuchs A; Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital of Augsburg, Augsburg, Germany., Wieser A; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Gall C; Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Wytopil M; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Mueller-Schmucker SM; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Beileke S; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Goekkaya M; Environmental Medicine, Faculty of Medicine, University of Augsburg, Institute of Environmental Medicine Helmholtz Zentrum München, German Research Center for Environmental Health, Augsburg, Germany., Kling E; Institute of Laboratory Medicine and Microbiology University Hospital Augsburg, Augsburg, Germany., Geldmacher C; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Rubio-Acero R; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Plank M; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany., Christa C; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany., Willmann A; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany., Vu M; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany., Einhauser S; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany., Weps M; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany., Lampl BMJ; Regensburg Department of Public Health, Division of Infection Control and Prevention, Regensburg, Germany; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany., Almanzar G; Pediatric Rheumatology / Special Immunology, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany., Kousha K; Pediatric Rheumatology / Special Immunology, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany., Schwägerl V; Pediatric Infectious Diseases, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany., Liebl B; Bavarian Health and Food Safety Authority (LGL), Oberschleißheim, Germany., Weber B; Institute for Information Systems, University of Applied Sciences Hof, Hof, Germany., Drescher J; smartlytic GmbH, Hof, Germany., Scheidt J; Institute for Information Systems, University of Applied Sciences Hof, Hof, Germany., Gefeller O; Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Messmann H; Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital of Augsburg, Augsburg, Germany., Protzer U; Institute of Virology, Technical University of Munich, School of Medicine, Munich, Germany; Institute of Virology, Helmholtz Munich, Munich, Germany, and German Center for Infection Research, Munich partner site., Liese J; Pediatric Infectious Diseases, Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany., Hoelscher M; Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Wagner R; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany., Überla K; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Steininger P; Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: philipp.steininger@uk-erlangen.de.

Publikováno v: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Feb; Vol. 170, pp. 105622. Date of Electronic Publication: 2023 Nov 28.

Cross-Reactivity Between Influenza Matrix- and HIV-1 P17-Specific CTL-A Large Cohort Study.

Autor: Hückelhoven AG; Infectious Disease Unit, Department of Internal Medicine III, Institute of Clinical Immunology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany; †Department of Medicine 5, University Hospital Heidelberg, Heidelberg, Germany; and ‡German Competence Network on HIV/AIDS., Etschel JK, Bergmann S, Zitzelsberger K, Mueller-Schmucker SM, Harrer EG, Harrer T

Publikováno v: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2015 Aug 15; Vol. 69 (5), pp. 528-35.

HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients.

Autor: Etschel JK; Infectious Diseases Unit, Department of Internal Medicine 3, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Hückelhoven AG, Hofmann C, Zitzelsberger K, Maurer K, Bergmann S, Mueller-Schmucker SM, Wittmann J, Spriewald BM, Dörrie J, Schaft N, Harrer T

Publikováno v: Journal of immunological methods [J Immunol Methods] 2012 Jun 29; Vol. 380 (1-2), pp. 40-55. Date of Electronic Publication: 2012 Apr 03.